Patent · US Active

Method for the production of hyperpolarized 129Xe

US8003077B2 · kind B2 · utility

0Cited by

2References

8Claims

0Family size

Assignee

GE HEALTHCARE AS · NO

Inventors

Jan Henrik Ardenkjaer-Larsen · Malmö, SE
Lennart Hansson · Tomelilla, SE
Haukur Johannesson · Lund, SE
Rolf Servin · Malmö, SE
Lars-Goran Wistrand · Oslo, NO

Key dates

Filing date	Oct 24, 2003
Grant date	Aug 23, 2011
Priority date	—
Expiry date	Feb 20, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K51/1206
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a method for the production of hyperpolarized 129Xe and to a method for the production of a contrast agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.